119 related articles for article (PubMed ID: 33754162)
1. [Deterioration of quality of life in patients with Hodgkin lymphoma in the 5 years after treatment completion: long-term data from the HD13, HD14 and HD15 studies].
Vordermark D
Strahlenther Onkol; 2021 May; 197(5):449-451. PubMed ID: 33754162
[No Abstract] [Full Text] [Related]
2. Cancer-related fatigue in patients with and survivors of Hodgkin's lymphoma: a longitudinal study of the German Hodgkin Study Group.
Kreissl S; Mueller H; Goergen H; Mayer A; Brillant C; Behringer K; Halbsguth TV; Hitz F; Soekler M; Shonukan O; Rueffer JU; Flechtner HH; Fuchs M; Diehl V; Engert A; Borchmann P;
Lancet Oncol; 2016 Oct; 17(10):1453-1462. PubMed ID: 27612583
[TBL] [Abstract][Full Text] [Related]
3. Intensified treatment of patients with early stage, unfavourable Hodgkin lymphoma: long-term follow-up of a randomised, international phase 3 trial of the German Hodgkin Study Group (GHSG HD14).
Gillessen S; Plütschow A; Fuchs M; Markova J; Greil R; Topp MS; Meissner J; Zijlstra JM; Eichenauer DA; Bröckelmann PJ; Diehl V; Borchmann P; Engert A; von Tresckow B
Lancet Haematol; 2021 Apr; 8(4):e278-e288. PubMed ID: 33770483
[TBL] [Abstract][Full Text] [Related]
4. Gonadal function and fertility in survivors after Hodgkin lymphoma treatment within the German Hodgkin Study Group HD13 to HD15 trials.
Behringer K; Mueller H; Goergen H; Thielen I; Eibl AD; Stumpf V; Wessels C; Wiehlpütz M; Rosenbrock J; Halbsguth T; Reiners KS; Schober T; Renno JH; von Wolff M; van der Ven K; Kuehr M; Fuchs M; Diehl V; Engert A; Borchmann P
J Clin Oncol; 2013 Jan; 31(2):231-9. PubMed ID: 23150709
[TBL] [Abstract][Full Text] [Related]
5. Health-Related Quality of Life in Patients With Hodgkin Lymphoma: A Longitudinal Analysis of the German Hodgkin Study Group.
Kreissl S; Müller H; Goergen H; Meissner J; Topp M; Sökler M; Markova J; Bernhard J; Greil R; von Tresckow B; Behringer K; Rüffer JU; Flechtner HH; Möstl M; Fuchs M; Engert A; Diehl V; Borchmann P
J Clin Oncol; 2020 Sep; 38(25):2839-2848. PubMed ID: 32574114
[TBL] [Abstract][Full Text] [Related]
6. [New therapeutic strategies for Hodgkin lymphoma in cooperation of radiation oncology and medical oncology].
Eich HT; Müller RP; Ansén S; Josting A; Engert A; Hansemann K; Pfistner B; Wolf J; Willich N; Diehl V
Rontgenpraxis; 2003; 55(3):114-24. PubMed ID: 15119314
[TBL] [Abstract][Full Text] [Related]
7. Quality control of involved field radiotherapy in the HD 13 and HD 14 trials : Report of the radiotherapy panel of the German Hodgkin Study Group (GHSG).
Kriz J; Baues C; Engenhart-Cabillic R; Haverkamp U; Herfart K; Lukas P; Plütschow A; Schmidberger H; Staar S; Fuchs M; Engert A; Eich HT
Strahlenther Onkol; 2017 Feb; 193(2):109-115. PubMed ID: 27596217
[TBL] [Abstract][Full Text] [Related]
8. Cancer-Related Fatigue in Patients With and Survivors of Hodgkin Lymphoma: The Impact on Treatment Outcome and Social Reintegration.
Behringer K; Goergen H; Müller H; Thielen I; Brillant C; Kreissl S; Halbsguth TV; Meissner J; Greil R; Moosmann P; Shonukan O; Rueffer JU; Flechtner HH; Fuchs M; Diehl V; Engert A; Borchmann P
J Clin Oncol; 2016 Dec; 34(36):4329-4337. PubMed ID: 27998235
[TBL] [Abstract][Full Text] [Related]
9. Outcome of Patients With Early-Stage Infradiaphragmatic Hodgkin Lymphoma: A Comprehensive Analysis From the German Hodgkin Study Group.
Sasse S; Goergen H; Plütschow A; Böll B; Eichenauer DA; Fuchs M; Behringer K; Zijlstra JM; Greil R; Markova J; Topp MS; Meissner J; Neubauer A; Baues C; Engert A; Borchmann P; von Tresckow B
J Clin Oncol; 2018 Sep; 36(25):2603-2611. PubMed ID: 29989855
[TBL] [Abstract][Full Text] [Related]
10. Impact of centralized diagnostic review on quality of initial staging in Hodgkin lymphoma: experience of the German Hodgkin Study Group.
Bröckelmann PJ; Goergen H; Fuchs M; Kriz J; Semrau R; Baues C; Kobe C; Behringer K; Eichenauer DA; von Tresckow B; Klimm B; Halbsguth T; Wongso D; Plütschow A; Haverkamp H; Dietlein M; Eich HT; Stein H; Diehl V; Borchmann P; Engert A
Br J Haematol; 2015 Nov; 171(4):547-56. PubMed ID: 26310520
[TBL] [Abstract][Full Text] [Related]
11. [FDG-PET in Hodgkin lymphoma].
Kobe C; Dietlein M; Mauz-Körholz C; Engert A; Borchmann P; Sabri O; Schober O; Schicha H; Kluge R
Nuklearmedizin; 2008; 47(6):235-8; quiz N75-6. PubMed ID: 19057796
[TBL] [Abstract][Full Text] [Related]
12. Bleomycin in older early-stage favorable Hodgkin lymphoma patients: analysis of the German Hodgkin Study Group (GHSG) HD10 and HD13 trials.
Böll B; Goergen H; Behringer K; Bröckelmann PJ; Hitz F; Kerkhoff A; Greil R; von Tresckow B; Eichenauer DA; Bürkle C; Borchmann S; Fuchs M; Diehl V; Engert A; Borchmann P
Blood; 2016 May; 127(18):2189-92. PubMed ID: 26834240
[TBL] [Abstract][Full Text] [Related]
13. Long-Term Follow-Up of Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma Treated in the HD7 to HD15 Trials: A Report From the German Hodgkin Study Group.
Eichenauer DA; Plütschow A; Fuchs M; Sasse S; Baues C; Böll B; von Tresckow B; Diehl V; Borchmann P; Engert A
J Clin Oncol; 2020 Mar; 38(7):698-705. PubMed ID: 31626571
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of first-line treatment options for patients with advanced-stage Hodgkin lymphoma: a modelling study.
Vijenthira A; Chan K; Cheung MC; Prica A
Lancet Haematol; 2020 Feb; 7(2):e146-e156. PubMed ID: 31948928
[TBL] [Abstract][Full Text] [Related]
15. Quality of life of long-term survivors with Hodgkin lymphoma after high-dose chemotherapy, autologous stem cell transplantation, and conventional chemotherapy.
Brandt J; Dietrich S; Meissner J; Neben K; Ho AD; Witzens-Harig M
Leuk Lymphoma; 2010 Nov; 51(11):2012-20. PubMed ID: 20858092
[TBL] [Abstract][Full Text] [Related]
16. Treatment of classical Hodgkin lymphoma in young adults aged 18-30 years with a modified paediatric Hodgkin lymphoma protocol. Results of a multicentre phase II clinical trial (CRUK/08/012).
Townsend W; Leong S; Hoskin P; Diez P; Patrick P; Linch D; Wong WL; Kayani I; Sanghera B; Lopes A; Daw S; Collins G; Clifton-Hadley L; Ardeshna K
Br J Haematol; 2020 Apr; 189(1):128-132. PubMed ID: 31710702
[TBL] [Abstract][Full Text] [Related]
17. Caring beyond cure: quality of life after high-dose chemotherapy for patients with relapsed Hodgkin lymphoma.
Borchmann P
Leuk Lymphoma; 2010 Nov; 51(11):1949-50. PubMed ID: 21077743
[No Abstract] [Full Text] [Related]
18. Assessment of tumor size reduction improves outcome prediction of positron emission tomography/computed tomography after chemotherapy in advanced-stage Hodgkin lymphoma.
Kobe C; Kuhnert G; Kahraman D; Haverkamp H; Eich HT; Franke M; Persigehl T; Klutmann S; Amthauer H; Bockisch A; Kluge R; Wolf HH; Maintz D; Fuchs M; Borchmann P; Diehl V; Drzezga A; Engert A; Dietlein M
J Clin Oncol; 2014 Jun; 32(17):1776-81. PubMed ID: 24799482
[TBL] [Abstract][Full Text] [Related]
19. Progression-free survival of early interim PET-positive patients with advanced stage Hodgkin's lymphoma treated with BEACOPP
Borchmann P; Haverkamp H; Lohri A; Mey U; Kreissl S; Greil R; Markova J; Feuring-Buske M; Meissner J; Dührsen U; Ostermann H; Keller U; Maschmeyer G; Kuhnert G; Dietlein M; Kobe C; Eich H; Baues C; Stein H; Fuchs M; Diehl V; Engert A
Lancet Oncol; 2017 Apr; 18(4):454-463. PubMed ID: 28236583
[TBL] [Abstract][Full Text] [Related]
20. Impact of Bleomycin and Vincristine Dose Reductions in Patients With Advanced Hodgkin Lymphoma Treated With BEACOPP: An Analysis of the German Hodgkin Study Group HD12 and HD15 Trials.
Haverkamp H; Böll B; Eichenauer DA; Sasse S; Fuchs M; Borchmann P; Diehl V; Engert A; von Tresckow B
J Clin Oncol; 2015 Aug; 33(22):2430-6. PubMed ID: 26101245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
